Appointment of Joint Corporate Broker

By

Regulatory News | 17 Sep, 2024

Updated : 09:14

RNS Number : 3894E
B.P. Marsh & Partners PLC
17 September 2024
 

17 September 2024

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

Appointment of Joint Corporate Broker

 

B. P. Marsh (AIM: BPM), the niche venture capital provider to early stage financial services businesses, today announces the appointment of Singer Capital Markets as joint corporate broker to the Company. Panmure Liberum Limited will remain as the Company's nominated adviser and joint corporate broker.

 

For further information:                                                                       

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112





Nominated Adviser & Joint Corporate Broker

Panmure Liberum Limited



Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500





Joint Corporate Broker

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

Financial PR & Investor Relations

 

 

+44 (0)20 7496 3000

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

 

- Ends -

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPFZGMLKVVGDZM

Last news